AP4E1
AP-4 complex subunit epsilon-1
Also known as: AP-4-EPSILON, AP4E1_HUMAN, SPG51
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UPM8
- Gene
- AP4E1
- Ensembl
- ENSG00000081014
- Chromosome
- 15
- Canonical length
- 1137 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
1137 residues, UniProt reviewed canonical sequence.
>Q9UPM8|AP4E1
1 MSDIVEKTLT ALPGLFLQNQ PGGGPAAAKA SFSSRLGSLV RGITALTSKH EEEKLIQQEL
61 SSLKATVSAP TTTLKMMKEC MVRLIYCEML GYDASFGYIH AIKLAQQGNL LEKRVGYLAV
121 SLFLHESHEL LLLLVNTVVK DLQSTNLVEV CMALTVVSQI FPCEMIPAVL PLIEDKLQHS
181 KEIVRRKAVL ALYKFHLIAP NQVQHIHIKF RKALCDRDVG VMAASLHIYL RMIKENSSGY
241 KDLTGSFVTI LKQVVGGKLP VEFNYHSVPA PWLQIQLLRI LGLLGKDDQR TSELMYDVLD
301 ESLRRAELNH NVTYAILFEC VHTVYSIYPK SELLEKAAKC IGKFVLSPKI NLKYLGLKAL
361 TYVIQQDPTL ALQHQMTIIE CLDHPDPIIK RETLELLYRI TNAQNITVIV QKMLEYLHQS
421 KEEYVIVNLV GKIAELAEKY APDNAWFIQT MNAVFSVGGD VMHPDIPNNF LRLLAEGFDD
481 ETEDQQLRLY AVQSYLTLLD MENVFYPQRF LQVMSWVLGE YSYLLDKETP EEVIAKLYKL
541 LMNDSVSSET KAWLIAAVTK LTSQAHSSNT VERLIHEFTI SLDTCMRQHA FELKHLHENV
601 ELMKSLLPVD RSCEDLVVDA SLSFLDGFVA EGLSQGAAPY KPPHQRQEEK LSQEKVLNFE
661 PYGLSFSSSG FTGRQSPAGI SLGSDVSGNS AETGLKETNS LKLEGIKKLW GKEGYLPKKE
721 SKTGDESGAL PVPQESIMEN VDQAITKKDQ SQVLTQSKEE KEKQLLASSL FVGLGSESTI
781 NLLGKADTVS HKFRRKSKVK EAKSGETTST HNMTCSSFSS LSNVAYEDDY YSNTLHDTGD
841 KELKKFSLTS ELLDSESLTE LPLVEKFSYC SLSTPSLFAN NNMEIFHPPQ STAASVAKES
901 SLASSFLEET TEYIHSNAME VCNNETISVS SYKIWKDDCL LMVWSVTNKS GLELKSADLE
961 IFPAENFKVT EQPGCCLPVM EAESTKSFQY SVQIEKPFTE GNLTGFISYH MMDTHSAQLE
1021 FSVNLSLLDF IRPLKISSDD FGKLWLSFAN DVKQNVKMSE SQAALPSALK TLQQKLRLHI
1081 IEIIGNEGLL ACQLLPSIPC LLHCRVHADV LALWFRSSCS TLPDYLLYQC QKVMEGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AP4E1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 7.7 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 7.7 nTPM
- thymus: 6.1 nTPM
- tongue: 5.9 nTPM
- lymph node: 5.1 nTPM
- skin: 5.1 nTPM
- parathyroid gland: 4.8 nTPM
Single-cell type
- somatotrophs: 70 nCPM
- myonuclei: 66 nCPM
- microglia: 65 nCPM
- lactotrophs: 62 nCPM
- thyrotrophs: 61 nCPM
- monocyte progenitors: 60 nCPM
Immune cell
- basophil: 2.7 nTPM
- intermediate monocyte: 0.9 nTPM
- naive CD8 T-cell: 0.9 nTPM
- gdT-cell: 0.8 nTPM
- memory CD8 T-cell: 0.7 nTPM
- classical monocyte: 0.6 nTPM
Brain region
- white matter: 6.8 nTPM
- cerebellum: 6.6 nTPM
- choroid plexus: 6.6 nTPM
- thalamus: 6.2 nTPM
- medulla oblongata: 5.9 nTPM
- basal ganglia: 5.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AP4E1.
Disease | AllUniProt
Conditions AP4E1 is implicated in, by any mechanism.
- Spastic paraplegia 51, autosomal recessive (SPG51) MIM:613744
- Stuttering, familial persistent 1 (STUT1) MIM:184450
Disease | GeneticClinVar
36 pathogenic / likely-pathogenic of 639 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spastic paraplegia
- Hereditary spastic paraplegia 51
- Stuttering, familial persistent, 1
- ALG12-congenital disorder of glycosylation
- Abnormality of the nervous system
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular protein localization
- intracellular protein transport
- protein targeting
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Clathrin/coatomer adaptor, adaptin-like, N-terminal
- Armadillo-like helical
- Armadillo-type fold
- Adaptor Complexes Large Subunit
- Adaptin N terminal region
- Adaptor protein complex AP-4, epsilon subunit
- AP-4 complex subunit epsilon-1, C-terminal
- Adaptin AP4 complex epsilon appendage platform
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AP4E1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AP4E1 as an antibody target. Whether an autoantibody or antibody against AP4E1 could matter depends on whether native AP4E1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AP4E1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AP4E1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...